Enzo Historical Cash Flow
| ENZ Stock | USD 1.08 0.05 4.85% |
Analysis of Enzo Biochem cash flow over time is an excellent tool to project Enzo Biochem future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Depreciation of 1.2 M or Other Non Cash Items of 4.7 M as it is a great indicator of Enzo Biochem ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Enzo Biochem latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Enzo Biochem is a good buy for the upcoming year.
Enzo |
About Enzo Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Enzo balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Enzo's non-liquid assets can be easily converted into cash.
Enzo Biochem Cash Flow Chart
Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Depreciation
Depreciation indicates how much of Enzo Biochem value has been used up. For tax purposes Enzo Biochem can deduct the cost of the tangible assets it purchases as business expenses. However, Enzo Biochem must depreciate these assets in accordance with IRS rules about how and when the deduction may be taken, and how long it will last. The systematic allocation of the cost of a tangible asset over its useful life.Capital Expenditures
Capital Expenditures are funds used by Enzo Biochem to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Enzo Biochem operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from Enzo Biochem's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Enzo Biochem current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enzo Biochem. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy Enzo Stock please use our How to Invest in Enzo Biochem guide.At this time, Enzo Biochem's Change To Inventory is fairly stable compared to the past year. Begin Period Cash Flow is likely to rise to about 87.5 M in 2024, despite the fact that Change In Cash is likely to grow to (29.5 M).
Enzo Biochem cash flow statement Correlations
Click cells to compare fundamentals
Enzo Biochem Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Enzo Biochem cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | 85K | (4.9M) | (2.7M) | (334K) | 1.1M | 1.1M | |
| Change In Cash | (12.3M) | (34.3M) | 8.3M | 60.8M | (31.0M) | (29.5M) | |
| Free Cash Flow | (19.3M) | (4.0M) | (20.1M) | (39.7M) | (26.8M) | (25.5M) | |
| Change In Working Capital | 8.0M | (4.8M) | (6.8M) | 18.6M | (8.3M) | (7.8M) | |
| Begin Period Cash Flow | 60.9M | 48.6M | 14.3M | 22.6M | 83.4M | 87.5M | |
| Other Cashflows From Financing Activities | 7.4M | (34.5M) | 25.2M | (372K) | (474K) | (450.3K) | |
| Depreciation | 2.8M | 2.7M | 2.8M | 2.7M | 1.3M | 1.2M | |
| Other Non Cash Items | (1.2M) | (7.0M) | 3.3M | (75.8M) | 4.5M | 4.7M | |
| Capital Expenditures | 2.2M | 4.4M | 3.5M | 2.8M | 545K | 517.8K | |
| Total Cash From Operating Activities | (17.2M) | 387K | (16.6M) | (37.0M) | (26.3M) | (24.9M) | |
| Net Income | (28.5M) | 7.9M | (18.3M) | 20.3M | (26.1M) | (24.8M) | |
| End Period Cash Flow | 48.6M | 14.3M | 22.6M | 83.4M | 52.4M | 41.6M | |
| Total Cash From Financing Activities | 7.0M | (242K) | (241K) | (1.1M) | (4.2M) | (4.0M) | |
| Stock Based Compensation | 1.8M | 1.6M | 2.3M | 3.1M | 2.3M | 2.1M | |
| Change To Netincome | 11.3M | (5.4M) | 1.7M | (78.5M) | (70.7M) | (67.1M) | |
| Change To Liabilities | 1.2M | (395K) | 390K | 1.2M | 1.0M | 567.2K | |
| Total Cashflows From Investing Activities | (2.2M) | (34.5M) | 25.2M | 99.0M | 113.8M | 119.5M | |
| Other Cashflows From Investing Activities | 0.0 | 101.7M | (30.1M) | 28.7M | 117.0M | 122.9M | |
| Change To Account Receivables | 1.6M | (1.1M) | (1.3M) | 5.0M | 2.5M | 2.6M | |
| Investments | (2.2M) | (34.5M) | 28.7M | 99.0M | (545K) | (517.8K) | |
| Net Borrowings | 7.0M | (339K) | (269K) | (1.1M) | (1.3M) | (1.2M) | |
| Cash And Cash Equivalents Changes | (4.1M) | 855K | (12.3M) | 8.4M | 7.6M | 7.9M | |
| Change To Operating Activities | 5.0M | 1.7M | (3.2M) | 12.7M | 14.6M | 15.3M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Enzo Stock Analysis
When running Enzo Biochem's price analysis, check to measure Enzo Biochem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enzo Biochem is operating at the current time. Most of Enzo Biochem's value examination focuses on studying past and present price action to predict the probability of Enzo Biochem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enzo Biochem's price. Additionally, you may evaluate how the addition of Enzo Biochem to your portfolios can decrease your overall portfolio volatility.